82 related articles for article (PubMed ID: 6113835)
1. Additional studies on side effects of melperone in long-term therapy for 1 to 15 years in psychiatric patients.
Kirkegaard A; Kirkegaard G; Geismar L; Christensen I
Arzneimittelforschung; 1981; 31(4):737-40. PubMed ID: 6113835
[TBL] [Abstract][Full Text] [Related]
2. Additional studies on side effects of melperone in long-term therapy for 1-20 years in psychiatric patients.
Christensen I; Geismar L; Kirkegaard A; Kirkegaard G
Arzneimittelforschung; 1986 May; 36(5):855-60. PubMed ID: 2873821
[TBL] [Abstract][Full Text] [Related]
3. A comparison of two doses of melperone, an atypical antipsychotic drug, in the treatment of schizophrenia.
Sumiyoshi T; Jayathilake K; Meltzer HY
Schizophr Res; 2003 Jul; 62(1-2):65-72. PubMed ID: 12765745
[TBL] [Abstract][Full Text] [Related]
4. [Side effects of methylperone in long-term therapy up to 8 years].
Kirkegaard G; Kirkegaard A
Arzneimittelforschung; 1974 Aug; 24(8):1115-7. PubMed ID: 4213783
[No Abstract] [Full Text] [Related]
5. Melperone, an aytpical antipsychotic drug with clozapine-like effect on plasma prolactin: contrast with typical neuroleptics.
Bobo WV; Jayathilake K; Lee MA; Meltzer HY
Hum Psychopharmacol; 2009 Jul; 24(5):415-22. PubMed ID: 19551763
[TBL] [Abstract][Full Text] [Related]
6. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
7. [Clinical factors related to gains in body mass index (BMI) among patients under long-term antipsychotic treatment].
Koga M
Seishin Shinkeigaku Zasshi; 2003; 105(4):473-88. PubMed ID: 12806910
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence and type of dermatologic disorders in psychiatric patients treated with psychotropic drugs].
Murak-Kozanecka E; Rabe-Jabłońska J
Psychiatr Pol; 2004; 38(3):491-505. PubMed ID: 15199658
[TBL] [Abstract][Full Text] [Related]
9. Movement disorders associated with neuroleptic treatment.
Wirshing WC
J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
[TBL] [Abstract][Full Text] [Related]
10. The clinical association of tardive dyskinesia and drug-induced parkinsonism.
Wolf ME; Chevesich J; Lehrer E; Mosnaim AD
Biol Psychiatry; 1983 Oct; 18(10):1181-8. PubMed ID: 6140032
[No Abstract] [Full Text] [Related]
11. Melperone in low doses in anxious neurotic patients. A double-blind placebo-controlled clinical study.
Pöldinger WJ
Neuropsychobiology; 1984; 11(3):181-6. PubMed ID: 6147789
[TBL] [Abstract][Full Text] [Related]
12. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
13. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
Plesnicar BK; Zalar B; Breskvar K; Dolzan V
J Psychopharmacol; 2006 Nov; 20(6):829-33. PubMed ID: 16478753
[TBL] [Abstract][Full Text] [Related]
14. [The pharmacological management of aggressive and autoaggressive behaviour in mentally retarded patients with melperone (author's transl)].
Hacke W
Pharmakopsychiatr Neuropsychopharmakol; 1980 Jan; 13(1):20-4. PubMed ID: 6102772
[TBL] [Abstract][Full Text] [Related]
15. [Neuroleptic-induced movement disorders: historical perspectives].
Wolf MA; Yassa R; Llorca PM
Encephale; 1993; 19(6):657-61. PubMed ID: 12404786
[TBL] [Abstract][Full Text] [Related]
16. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
Curran S; Turner D; Musa S; Wattis J
Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
[TBL] [Abstract][Full Text] [Related]
18. A review of liver function tests during treatment with atypical antipsychotic drugs: a chart review study.
Atasoy N; Erdogan A; Yalug I; Ozturk U; Konuk N; Atik L; Ustundag Y
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1255-60. PubMed ID: 17600607
[TBL] [Abstract][Full Text] [Related]
19. Predicting the long-term risk of tardive dyskinesia in outpatients maintained on neuroleptic medications.
Glazer WM; Morgenstern H; Doucette JT
J Clin Psychiatry; 1993 Apr; 54(4):133-9. PubMed ID: 8098030
[TBL] [Abstract][Full Text] [Related]
20. Clozapine maintenance therapy in schizophrenia.
Gaszner P; Makkos Z
Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
